Neuro-Oncology Reviews
Volume
24 Number 8
30 April 2022
Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 8, 30 April
Bernstock
JD, Kang KD, Klinger NV, Olsen HE, Gary S, Totsch SK,
Ghajar-Rahimi G, Segar D, Thompson EM, Darley-Usmar V, Mott BT,
Peruzzotti-Jametti L, Friedman GK.
Targeting
oncometabolism to maximize immunotherapy in malignant brain
tumors.
Oncogene.
2022 Apr 16→.
doi: 10.1038/s41388-022-02312-y→.
PMID: 35430605→.
Review˰ ˍ
Daei
Sorkhabi A, Sarkesh A, Saeedi H, Marofi F, Ghaebi M, Silvestris N,
Baradaran B, Brunetti O.
The
Basis and Advances in Clinical Application of
Cytomegalovirus-Specific
Cytotoxic T Cell Immunotherapy for Glioblastoma
Multiforme.
Front
Oncol. 2022 Apr 19;12:818447→.
doi: 10.3389/fonc.2022.818447→.
PMID: 35515137→.
Review. ˍ
Khabibov
M, Garifullin A, Boumber Y, Khaddour K, Fernandez M, Khamitov F,
Khalikova L, Kuznetsova N, Kit O, Kharin L.
Signaling
pathways and therapeutic
approaches
in glioblastoma multiforme (Review).
Int
J Oncol. 2022 Apr 19;2022 Jun;60(6):69→.
doi: 10.3892/ijo.2022.5359→.
PMID: 35445737→.
Review. ˍ
Prada
F, Ciocca R, Corradino N, Gionso M, Raspagliesi L, Vetrano IG,
Doniselli F, Del Bene M, DiMeco F.
Multiparametric
Intraoperative Ultrasound in
Oncological
Neurosurgery: A Pictorial Essay.
Front
Neurosci. 2022 Apr 19;16:881661→.
doi: 10.3389/fnins.2022.881661→.
PMID: 35516800→.
Review. ˍ
Darbari
S, Manjunath N, Doddamani RS, Meena R, Nambirajan A, Sawarkar D,
Singh PK, Garg K, Chandra PS, Kale SS.
Primary
spinal cord glioblastoma
multiforme:
a single-center experience.
Br
J Neurosurg. 2022 Apr 20:1-7→.
doi: 10.1080/02688697.2022.2064427→.
PMID: 35441567→.
Review and Guidelines˰
ˍ
Tan
I, Pandit AS, Joshi S, Khan M, Sayar Z, Westwood JP, Cohen H, Toma
AK.
Pharmacological
venous thromboembolism prophylaxis in elective cranial surgery:
a
systematic review of time of initiation, regimen and duration.
Br
J Neurosurg. 2022 Apr 21:1-8→.
doi: 10.1080/02688697.2022.2064429→.
PMID: 35445634→.
Review˰ ˍ
Silva
MA, Mirchia K, Chamyan G, Maher O, Wang S, Niazi T.
Disseminated
diffuse
midline glioma associated with poorly differentiated orbital
lesion and
metastases
in an 8-year-old girl: case report and literature review.
Childs
Nerv Syst. 2022 Apr 23→.
doi: 10.1007/s00381-022-05530-7→.
PMID: 35460354→.
Case report and Review˰ ˍ
Haddad
AF, Young JS, Morshed RA, Berger MS.
FLAIRectomy:
Resecting beyond the Contrast Margin for Glioblastoma.
Brain
Sci. 2022 Apr 25;12(5):544→.
doi: 10.3390/brainsci12050544→.
PMID: 35624931→.
Review. ˍ
Salari
N, Fatahian R, Kazeminia M, Hosseinian-Far A, Shohaimi S,
Mohammadi M.
Patients'
Survival with Astrocytoma After Treatment: a Systematic Review and
Meta-analysis of Clinical Trial Studies.
Indian
J Surg Oncol. 2022 Apr 25, 2022;13(2):329-342→.
doi: 10.1007/s13193-022-01533-7→.
PMID: 35782798→.
Review, Meta-analysis˰ ˍ
Ghajar-Rahimi
G, Kang KD, Totsch SK, Gary S, Rocco A, Blitz S, Kachurak K,
Chambers MR, Li R, Beierle E, Bag A, Johnston JM, Markert JM,
Bernstock JD, Friedman GK.
Clinical
advances in oncolytic virotherapy for pediatric brain
tumors.
Pharmacol
Ther. 2022 Apr 26:108193→.
doi: 10.1016/j.pharmthera.2022.108193→.
PMID: 35487285→.
Review˰ ˍ
Pająk
B.
Looking
for the Holy Grail-Drug Candidates for Glioblastoma Multiforme
Chemotherapy.
Biomedicines.
2022 Apr 26;10(5):1001→.
doi: 10.3390/biomedicines10051001→.
PMID: 35625738→.
Review. ˍ
Miller
JJ.
Targeting
IDH-Mutant Glioma.
Neurotherapeutics.
2022 Apr 27→.
doi: 10.1007/s13311-022-01238-3→.
PMID: 35476295→.
Review. ˍ
Mount
CW, Gonzalez Castro LN.
Advances
in Chimeric Antigen Receptor (CAR) T-Cell Therapies for the
Treatment of Primary Brain Tumors.
Antibodies
(Basel). 2022 Apr 27;11(2):31→.
doi: 10.3390/antib11020031→.
PMID: 35645204→.
Review.
ˍ
Persson
ML, Douglas AM, Alvaro F, Faridi P, Larsen MR, Alonso MM, Vitanza
NA, Dun MD.
The
intrinsic and microenvironmental features of diffuse midline
glioma;
implications
for the development of effective immunotherapeutic treatment
strategies.
Neuro
Oncol. 2022 Apr 27:noac117→.
doi: 10.1093/neuonc/noac117→.
PMID: 35481923→.
Review. ˍ
Niedbała
M, Malarz K, Sharma G, Kramer-Marek G, Kaspera W.
Glioblastoma:
Pitfalls
and Opportunities of Immunotherapeutic Combinations.
Onco
Targets Ther. 2022 Apr 28;15:437-468→.
doi: 10.2147/OTT.S215997→.
PMID: 35509452→.
Review. ˍ
Golpayegani
M, Edalatfar M, Ahmadi A, Sadeghi-Naini M, Salari F, Hanaei S,
Shokraneh F, Ghodsi Z, Vaccaro AR, Rahimi-Movaghar V.
Complete
Versus Incomplete
Surgical
Resection in Intramedullary Astrocytoma: Systematic Review with
Individual
Patient Data Meta-Analysis.
Global
Spine J. 2022 Apr 29:21925682221094766→.
doi: 10.1177/21925682221094766→.
PMID: 35486519→.
Review and Meta-analysis. ˍ
Kim
YZ, Kim CY, Lim DH.
The
Overview of Practical Guidelines for Gliomas by
KSNO,
NCCN, and EANO.
Brain
Tumor Res Treat. 2022 Apr 29;10(2):83-93→.
doi: 10.14791/btrt.2022.0001→.
PMID: 35545827→.
Guidelines. ˍ
*
Venkataramani
V, Schneider M, Giordano FA, Kuner T, Wick W, Herrlinger U,
Winkler F.
Disconnecting
multicellular networks in brain tumours.
Nat
Rev Cancer. 2022 Apr 29→.
doi: 10.1038/s41568-022-00475-0→.
PMID: 35488036→.
Review˰ ˍ
Vuong
HG, Le HT, Jea A, McNall-Knapp R, Dunn IF.
Risk
stratification of H3
K27M-mutant
diffuse midline gliomas based on anatomical locations: an
integrated
systematic
review of individual participant data.
J
Neurosurg Pediatr. 2022 Apr 29:1-8→.
doi: 10.3171/2022.3.PEDS2250→.
PMID: 35535848→.
Review˰ ˍ
Nikova
AS, Sioutas G, Karanikas M, Birbilis T.
"Security
dilemma": active immunotherapy before versus after radiation
therapy alone or chemo-radiotherapy for newly diagnosed
glioblastoma.
Folia
Med (Plovdiv). 2022 Apr 30;64(2):195-201→.
doi: 10.3897/folmed.64.e62981→.
PMID: 35851769→.
Review. ˍ
Sursal
T, Ronecker JS, Dicpinigaitis AJ, Mohan AL, Tobias ME, Gandhi CD,
Jhanwar-Uniyal M.
Molecular
Stratification of Medulloblastoma: Clinical Outcomes
and
Therapeutic Interventions.
Anticancer
Res. 2022 Apr 30;42(5):2225-2239→.
doi: 10.21873/anticanres→.15703.
PMID: 35489737→.
Review. ˍ